Author:
Tanji Nozomu,Fukumoto Tetsuya,Miura Noriyoshi,Yanagihara Yutaka,Shirato Akitomi,Azuma Koji,Miyauchi Yuki,Kikugawa Tadahiko,Shimamoto Kenji,Yokoyama Masayoshi
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference28 articles.
1. National Cancer Center, Center for cancer control and information services (2011) Cancer statistics in Japan 2010. http://ganjoho.jp/public/statistics/backnumber/2010_en.html
2. Saxman SB, Propert KJ, Einhorn LH et al (1997) Long-term follow-up of a Phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 15:564–570
3. Stadler WM, Kuzel TM, Raghavan D et al (1997) Metastatic bladder cancer: advances in treatment. Eur J Cancer 33:S23–S26
4. von der Maase H, Sengelov L, Roberts JT et al (2005) Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23:4602–4608
5. Tanji N, Ozawa A, Miura N et al (2010) Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas. Int J Clin Oncol 15:369–375
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献